Neurodevelopmental Outcomes after Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity: A Prospective Case-Control Study |
| |
| Affiliation: | 1. Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan;2. Department of Child Psychiatry and Sleep Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan;3. College of Medicine, Chang Gung University, Taoyuan, Taiwan;4. Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan;5. Department of Nursing, Yuanpei University of Medical Technology, Hsinchu, Taiwan;1. Retina Department, Asociacion Para Evitar la Ceguera en Mexico, I.A.P. Hospital “Dr. Luis Sanchez Bulnes”, Coyoacan, Mexico City;2. Ophthalmology Department, Denver Health Medical Center, School of Medicine, University of Colorado, Denver, CO;1. University of Chicago, Department of Ophthalmology and Visual Science, Chicago, Illinois;2. Retina Consultants, Ltd, Des Plaines, Illinois;1. Department of Ophthalmology, University Hospital of Maracaibo, Maracaibo, Venezuela;2. Department of Ophthalmology, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil;1. Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada;2. Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada;1. Department of Pediatrics and Center for Global Health, University of Illinois at Chicago, Chicago, IL, USA;2. Pediatric Ophthalmology, Aravind Eye Care System, Madurai, Tamil Nadu, India;3. Vitrio Retinal Surgery, Aravind Eye Care System, Madurai, Tamil Nadu, India;4. Ophthalmic Therapy, Aravind Eye Care System, Madurai, Tamil Nadu, India;5. Bio-Statistics, Aravind Eye Care System, Madurai, Tamil Nadu, India;6. Department of Pediatric Ophthalmology, Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, USA |
| |
| Abstract: | |
| |
| Keywords: | ANOVA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0015" }," $$" :[{" #name" :" text" ," _" :" analysis of variance BEAT-ROP" },{" #name" :" keyword" ," $" :{" id" :" kwrd0025" }," $$" :[{" #name" :" text" ," _" :" Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity Bayley III" },{" #name" :" keyword" ," $" :{" id" :" kwrd0035" }," $$" :[{" #name" :" text" ," _" :" Bayley Scales of Infant and Toddler Development, Third Edition BW" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" birth weight D" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" diopter GA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" gestational age IVB" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" intravitreal injection of bevacizumab IVI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" intravitreal injection NICU" },{" #name" :" keyword" ," $" :{" id" :" kwrd0105" }," $$" :[{" #name" :" text" ," _" :" neonatal intensive care unit OR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0115" }," $$" :[{" #name" :" text" ," _" :" odds ratio ROP" },{" #name" :" keyword" ," $" :{" id" :" kwrd0125" }," $$" :[{" #name" :" text" ," _" :" retinopathy of prematurity VEGF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0135" }," $$" :[{" #name" :" text" ," _" :" vascular endothelial growth factor partial eta squared |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
